(Q38050375)

27 August 2017

title

Treatment of colorectal cancer in older patients (English)

1 reference

27 August 2017

1 reference

1 reference

Riccardo A Audisio

1

1 reference

27 August 2017

Demetris Papamichael

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

9 October 2012

1 reference

Nature Reviews Gastroenterology & Hepatology

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

716-725

1 reference

Estimates of cancer incidence and mortality in Europe in 2008.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Cancer screening in elderly patients: a framework for individualized decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

The cancer survival gap between elderly and middle-aged patients in Europe is widening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Neoadjuvant therapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Controversies of total mesorectal excision for rectal cancer in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

The effect of age on the quality of life of patients living with stomas: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Outcomes of laparoscopic surgery for colorectal cancer in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Reduced risk of medical morbidity and mortality in patients selected for laparoscopic colorectal resection in England: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Transanal endoscopic microsurgery for T1 rectal cancer: size matters!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Nonoperative approaches to rectal cancer: a critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Principles of surgical oncology in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Poor 1-year survival in elderly patients undergoing nonelective colorectal resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Elective surgery for gastrointestinal tumours in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Guidelenines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Surgical management of oncogeriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

When Reporting on Older Patients with Cancer, Frailty Information is Needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Enhanced recovery program following colorectal resection in the elderly patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Capecitabine as adjuvant treatment for stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Randomised trials of HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Liver resection for colorectal liver metastases in older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

The continuum of care: a paradigm for the management of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Chemotherapy with preoperative radiotherapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Postoperative complications following surgery for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Volume-outcome analysis of colorectal cancer-related outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Safety of bowel resection for colorectal surgical emergency in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Prediction of postoperative mortality in elderly patients with colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Improved survival in cancer of the colon and rectum in Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable rectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Efficacy and safety of colonic stenting for malignant disease in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: A prospective observational cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Chemotherapy: Is adjuvant chemotherapy an option for stage II colon cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Tri

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

The TME Trial After a Median Follow-up of 6 Years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Age is not a limiting factor for radical radiotherapy in pelvic malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.196

Capecitabine monotherapy in metastatic colorectal cancer

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23045000

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23045000

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2012.196

1 reference

Dimensions Publication ID

27 August 2017

1027683323

0 references

1 reference